{
    "id": "correct_subsidiary_00097_0",
    "rank": 34,
    "data": {
        "url": "https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/cci-clears-abbott-st-jude-deal-subject-to-voluntary-remedies/articleshow/56046328.cms",
        "read_more_link": "",
        "language": "en",
        "title": "CCI clears Abbott-St Jude deal subject to 'voluntary remedies'",
        "top_image": "https://img.etimg.com/thumb/msid-56046328,width-1200,height-630,imgsize-396700,overlay-economictimes/photo.jpg",
        "meta_img": "https://img.etimg.com/thumb/msid-56046328,width-1200,height-630,imgsize-396700,overlay-economictimes/photo.jpg",
        "images": [
            "https://img.etimg.com/photo/msid-76920425,quality-100/et-logo.jpg",
            "https://img.etimg.com/photo/msid-111867794,quality-100/et-logo.jpg",
            "https://img.etimg.com/photo/104857408.cms",
            "https://img.etimg.com/thumb/msid-56046328,width-300,height-225,imgsize-396700,resizemode-75/.jpg",
            "https://img.etimg.com/thumb/msid-111996515,imgsize-120106,width-138,height-104,quality-100/prime/money-and-markets/a-concrete-reason-why-adani-is-fighting-birla-in-this-key-sector.jpg",
            "https://img.etimg.com/thumb/msid-111996607,imgsize-74464,width-138,height-104,quality-100/prime/transportation/can-indigo-repeat-its-record-inr3k-crore-profit-these-factors-will-decide-.jpg",
            "https://img.etimg.com/thumb/msid-111983991,imgsize-237812,width-138,height-104,quality-100/prime/technology-and-startups/fm-played-angel-but-demons-are-still-lurking-for-thousands-of-startups.jpg",
            "https://img.etimg.com/thumb/msid-111992655,imgsize-1445342,width-138,height-104,quality-100/prime/economy-and-policy/will-the-government-reinstate-indexation-benefit-for-real-estate.jpg",
            "https://img.etimg.com/thumb/msid-111986677,imgsize-15184,width-138,height-104,quality-100/markets/stocks/news/stock-radar-gujarat-gas-takes-support-above-neckline-of-a-4-month-consolidation-should-you-buy.jpg",
            "https://img.etimg.com/thumb/msid-111978190,imgsize-94274,width-138,height-104,quality-100/markets/stocks/news/stock-pick-for-next-5-years-for-risk-taker-with-patience-7-stocks-where-budget-may-lead-to-real-change-in-business.jpg",
            "https://img.etimg.com/photo/msid-109982599,imgsize-67937/desktop-rhs-on-rise-section.jpg",
            "https://img.etimg.com/photo/msid-74462387,quality-100/et-logo.jpg",
            "https://img.etimg.com/photo/msid-74451948,quality-100/et-logo.jpg",
            "https://img.etimg.com/photo/47865640.cms"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Abbott",
            "Competition Commission of India",
            "Abbott Laboratories",
            "GlaxoSmithKline"
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2016-12-18T12:23:00+05:30",
        "summary": "",
        "meta_description": "In a tweet, Competition Commission of India (CCI) said it has approved the \"proposed combination between St Jude Medical and Abbott Laboratories; subject to voluntary remedies\".",
        "meta_lang": "en",
        "meta_favicon": "https://economictimes.indiatimes.com/icons/etfavicon.ico",
        "meta_site_name": "The Economic Times",
        "canonical_link": "https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/cci-clears-abbott-st-jude-deal-subject-to-voluntary-remedies/articleshow/56046328.cms",
        "text": "(Catch all the Business News, Breaking News, Budget 2024 Events and Latest News Updates on The Economic Times.)\n\nSubscribe to The Economic Times Prime and read the ET ePaper online."
    }
}